Core Viewpoint - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation through a workshop organized by Shanghai Jiao Tong University School of Medicine and its affiliated institutions [1][4]. Training Highlights - The workshop aims to merge medical pain points with engineering technology to create innovative medical products and facilitate results transformation [4]. - Participants will learn the Biodesign innovation methodology, which is a global leading model for medical engineering innovation, focusing on efficient transformation [5]. - The program includes insights into the medical device industry trends, practical empowerment through design thinking and interdisciplinary collaboration, and opportunities for project exposure to potential investors [5]. Target Audience - The workshop is suitable for various professionals including doctors, medical technicians, engineering personnel from research institutions, industry practitioners, investors, and entrepreneurs interested in medical device innovation [5]. Course Schedule - The two-day intensive training covers medical innovation and technology layout, innovation practice, team exercises, and discussions on the key paths from concept to market [6][10][12]. - The first day includes sessions on medical innovation, technology layout, and practical exercises to foster collaboration among participants [6][8]. - The second day focuses on the industrialization of innovation and funding pathways, including a visit to the Ruijin Hospital's translational medicine center [12][15]. Expert Team - The workshop features a team of distinguished experts from Shanghai Jiao Tong University, including leaders in biomedical engineering and medical technology innovation with extensive experience in research and investment [13][16]. Registration Information - The workshop is scheduled for June 21-22, 2025, at Shanghai Jiao Tong University School of Medicine, with a fee of 8999 yuan per participant [9][18].

Core Viewpoint - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation through a workshop organized by Shanghai Jiao Tong University School of Medicine and its affiliated institutions [1][3]. Course Highlights - The workshop aims to integrate medical pain points with engineering technology to create innovative medical products and facilitate results transformation [3]. - Participants will learn the complete path from concept to market for medical devices, utilizing the Biodesign innovation methodology [3][7]. - The program includes expert instruction from top medical engineering professionals and opportunities for networking across disciplines [3][9]. Target Audience - The workshop is suitable for various professionals, including doctors, medical technicians, engineering personnel from research institutions, industry practitioners, investors, and entrepreneurs interested in medical device innovation [3][12]. Training Information - The workshop is scheduled for June 21-22, 2025, at Shanghai Jiao Tong University School of Medicine, with a fee of 8999 yuan per person [3][12]. Course Structure - The first day focuses on medical innovation and technology layout, including practical exercises and discussions to foster collaboration among participants [4][6]. - The second day covers innovation commercialization and funding pathways, including insights into financing and government support policies [8][12]. Expert Team - The workshop features a team of distinguished experts with extensive experience in medical technology and investment, including leaders from Shanghai Jiao Tong University and successful entrepreneurs in the medical field [9][10].

Group 1 - The core viewpoint of the article highlights the recent developments and future events related to the medical technology industry, particularly focusing on Aiyisheng Medical's advancements in artificial blood vessels [1][3][4] - Aiyisheng Medical, established in 2023 and headquartered in Guangzhou, specializes in the development, production, and sales of high-end implantable medical devices, with a focus on small-diameter artificial blood vessels [3][4] - The company has formed deep collaborations with Wuhan University of Technology and domestic clinical medical experts to promote the integration of medicine and engineering, aiming to enhance the industry chain [3][4] Group 2 - Aiyisheng Medical recently completed its first clinical trial implantation of a domestically produced puncture-type artificial blood vessel, marking a significant milestone for the company [4] - The unique puncture-type design of the artificial blood vessel allows for dialysis puncture within three days post-surgery, significantly reducing patient waiting time compared to traditional artificial blood vessels, which typically require 4-8 weeks for swelling to subside [6] - The product demonstrates notable advantages in long-term patency, repeated puncture tolerance, and surgical suturing convenience, positioning it as a competitive solution in the market traditionally dominated by imported products [6]

Core Insights - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation [1] - It highlights the "Medical Device Innovation and Engineering Transformation Workshop" organized by Shanghai Jiao Tong University, which aims to merge medical needs with engineering solutions [1][3] Course Highlights - Participants will learn to integrate medical pain points with engineering technology to create innovative medical products [3] - The workshop will cover the complete path from concept to market for medical devices, utilizing the Biodesign innovation methodology [3][7] - Attendees will have the opportunity to network with professionals from various fields, including doctors, engineers, and investors [3][12] Training Information - The workshop is scheduled for June 21-22, 2025, at Shanghai Jiao Tong University, with a fee of 8999 yuan per person [3][12] - The program is supported by the Zhongguancun Lianxin Biomedical Industry Alliance [3] Course Structure - Day one focuses on medical innovation and technology layout, including practical exercises and case discussions to foster collaboration among participants [4][6] - Day two will address innovation commercialization and funding pathways, including insights into medical device financing and government support policies [8][12] Expert Faculty - The faculty includes leading experts from Shanghai Jiao Tong University with extensive experience in medical technology and investment [9][10] - Notable faculty members have backgrounds in medical chip research, nanobiomedicine, and healthcare investment [9][10] Networking Opportunities - The workshop will feature a technology solution matching session, allowing participants to connect with experts and explore potential collaborations [8][11] - Participants will have the chance to showcase their projects and receive feedback from mentors, enhancing their visibility to potential investors [11]

Core Insights - The article highlights the significant advancements and market position of Jiangsu Suzhou-based company, Peijia Medical, particularly its subsidiary, Gaki Bio, in the neuro-interventional medical device sector [1][2][3] Group 1: Company Overview - Gaki Bio, established in 2006, has developed China's first commercialized spring coil and offers a comprehensive range of products addressing hemorrhagic, ischemic, and access solutions [1] - The company is expected to break even in 2024, marking an 18-year journey from obscurity to industry leadership [1] Group 2: Product Development and Market Strategy - The Syphonet thrombectomy stent, launched in February 2022, quickly became the market leader among domestic products, showcasing Gaki Bio's effective research and development strategy [2] - Gaki Bio's approach involves launching a complete suite of products simultaneously to address all surgical needs, enhancing the usability and effectiveness of their devices [2] - The Fastunnel delivery balloon catheter, approved in May 2022, features an integrated design that simplifies complex procedures, reducing the number of steps required in surgeries [3][4] Group 3: Innovation and Clinical Needs - Gaki Bio has developed 16 products that have received approval for sale, with plans to submit 5 to 6 additional registration applications this year, focusing on unmet clinical needs [4] - The company has adopted a "medical-engineering collaboration" innovation methodology, which has proven effective in the neuro-interventional device market [3][4] Group 4: Operational Efficiency and Supply Chain - Gaki Bio has achieved over 90% localization in its supply chain, sourcing more than 90% of its raw materials from domestic suppliers, which enhances cost efficiency and responsiveness [5][6] - The company has implemented lean production standards, resulting in increased operational efficiency and a reported gain of over 20 million yuan in product development [5][6]

Core Viewpoint - The establishment of the "Key Laboratory of Rehabilitation Aids" by the Ministry of Civil Affairs marks a significant milestone for the rehabilitation aids industry in Shenzhen, aiming to overcome technological bottlenecks and promote the intelligent and precise upgrade of domestic rehabilitation aids [1][2][3] Group 1 - The laboratory will focus on three main directions: the development of intelligent rehabilitation aids, technology for reconstructing motor functions, and personalized adaptation of aids [1][2] - Key technological breakthroughs will include advancements in 3D printing lightweight biomaterials, precision transmission, intelligent sensing, and AI motion analysis algorithms [1][2] - The laboratory aims to create China's first standard database for the adaptation of rehabilitation aids based on sports injury recovery through real-time data collection from multi-modal sensors [1][3] Group 2 - The laboratory's establishment is part of a broader initiative to develop a comprehensive sports medicine and rehabilitation center in Shenzhen, integrating research, clinical practice, and public health [2][3] - Shenzhen is one of the first 12 comprehensive innovation pilot areas for rehabilitation aids in China, leveraging its industrial cluster advantages to enhance the development of key technologies [3] - The laboratory will facilitate collaboration between medical and engineering sectors, accelerating the full-chain ecosystem of clinical needs, research innovation, and industrial application [3]

Core Viewpoint - The article emphasizes the collaboration between doctors, CEOs, engineers, and investors to address challenges in medical device innovation through a workshop organized by Shanghai Jiao Tong University School of Medicine and its affiliated institutions [1][4]. Training Highlights - The workshop aims to merge medical pain points with engineering technology to create innovative medical products and facilitate results transformation [4]. - Participants will learn the Biodesign innovation methodology, which is a global leading model for medical engineering innovation, focusing on efficient transformation [5]. - The program includes insights into the medical device industry trends, practical empowerment through design thinking and interdisciplinary collaboration, and opportunities for project exposure to potential investors [5]. Target Audience - The workshop is suitable for various professionals, including doctors from different departments, engineering personnel from research institutions, industry and investment practitioners, and entrepreneurs interested in medical device innovation [5]. Course Structure - The two-day intensive training covers medical innovation and technology layout, innovation practice, team exercises, and discussions on the key paths from concept to market [6][10]. - The first day includes sessions on medical innovation, technology layout, and practical exercises to foster collaboration among participants [6][8]. - The second day focuses on innovation industrialization and funding pathways, including discussions on financing, government support policies, and investment opportunities [12][15]. Expert Faculty - The workshop features a team of distinguished experts from Shanghai Jiao Tong University, including leaders in biomedical engineering and medical technology innovation, who will share their insights and experiences [13][16]. Registration Information - The workshop is scheduled for June 21-22, 2025, at Shanghai Jiao Tong University School of Medicine, with a fee of 8999 yuan per person, covering course materials and refreshments [9][18].

三轴全向踝关节康复机械人，拍摄：实习生莫林衛 蔡璟补充道，这些丰富的医疗数据为人工智能模型的开发提供了宝贵的资源，香港可以充分利用内地的 医疗数据优势，在人工智能模型开发过程中更好地实现技术落地与应用。通过充分利用内地的医疗数 据，企业能够开发出更具针对性和实用性的产品，更好地满足市场需求。这种优势不仅为香港的科技企 业带来了发展机遇，也为全球医疗科技的发展提供了新的思路和方向。 蔡璟团队研发的人工智能系统，可自动分析患者CT影像生成肺部功能影像，并通过"功能引导"放射治 疗技术设计个性化方案，降低对高功能区域的放射损伤。该系统采用尖端算法训练模型，兼容主流放疗 设备，目前正在香港和内地医院开展临床测试，并计划扩展至肝脑肿瘤治疗。 本次分享会上，香港理工大学武汉科技创新研究院院长何明光带来了其团队的最新成果，该产品创新应 用生成式AI，仅凭普通眼底照片即可生成高精度血管造影影像，该产品现于粤港澳大湾区顶尖机构进 行多中心试验；南京技术创新研究院院长张丹则带来了其团队首创的三轴全向踝关节康复机械人，该设 备正与上海华山医院合作临床测试，未来将结合AI提供个性化方案，并拟扩展至肩手关节康复领域。 蔡璟团队研发的自 ...

4月23日，"科技美学新格式"YOUMAGIC溯源——清华高能单极射频新生分享会在无锡圆满落幕。无锡 市新吴区副区长姬旭，以及清华大学顶尖学者、三甲医院临床专家、多平台营销专家以及医美机构创始 人、院长等行业领袖出席活动。通过清华技术溯源、临床结果实证、工厂实地探访、营销增长方法论分 享等环节，活动全面展示了YOUMAGIC单极射频的创新成果，以及医工结合的产业化模式和清华智造 实力，重塑科技美学新范式，为行业高质量发展注入新活力。 溯源清华能量源技术，以实力重新定义抗衰新标准 在行业技术与消费升级的背景下，活动聚焦前沿技术创新，通过多轮分享展示中国"智造"实力，以硬核 技术重塑抗衰标准，助力参会者把握行业新机遇。 活动伊始，无锡市新吴区副区长姬旭致开幕词，对YOUMAGIC的创新成果表示高度认可。他表示，威 脉医疗作为无锡国际生命科学创新园的标杆企业，落地园区以来快速发展，展现了"无锡智造"的硬核实 力。未来园区将继续以开放包容姿态拥抱创新，持续深化医工结合，以"精准政策+资本赋能+生态协 同"体系赋能企业长期发展。 随后，威脉医疗创始人兼CEO李天民围绕清华智造及YOUMAGIC的硬核技术进行分享。他提到 ...

一次创新思维的碰撞，一场探索医疗科技创新的合作之旅！ 医生 ×CEO ×工程师 ×投资人 强强联合，破解医疗器械创新难题！ 如果你对 医疗器械创新、医工结合、技术转化 充满兴趣，那么这次 上海交通大学医学院 × 附属医院 × 生物医学工程学院 联合打造的 「医疗器械医工创新转化工作 坊」 ，就是你的绝佳机会！ 课程亮点 你将获得 培训信息 时间： 2025年6月（周末2天，具体时间提前一个月通知） 地点： 上海交通大学医学院 费用： 8999元/人（含课程、教材、茶点等，食宿自理） 主办单位： 上海交通大学医学院继续教育学院 支持 单位： 中关村联新生物医药产业联盟 第一天：医疗创新与技术布局 晚上：技术解决方案对接会 第二天：创新产业化与资金路径 医工创新产业的关键点及资金来源 课程安排 课程安排 | 2天高强度实战训练，全面掌握医工创新转化 让医学痛点与工程技术深度融合，打造医疗创新产品，助力成果转化！ 是否曾有一个医疗创新的想法，却不知如何落地？ 是否苦于医生与工程技术团队难以有效协作？ 是否希望掌握医疗器械从概念到市场的完整路径？ Biodesign 医工创新方法论： 全球前沿医工创新模式，助力高效转 ...